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ROLE OF GAMMA GLUTAMYL TRANSFERASE 
LEVELS IN PREDICTION OF CARDIO VASCULAR 
RISK IN PATIENTS WITH NON-ALCOHOLIC FATTY 
LIVER DISEASE   
BACKGROUND : Non – alcoholic fatty liver disease (NAFLD) is one among 
those multiple conditions causing derangement of liver function tests.As it is very 
well understood that NAFLD has a correlation with artherosclerosis without much 
influence from some of those essential risk factors like smoking , systolic blood 
pressure , total cholesterol values and age factors which are usually independent 
risk factors.  AIM : To confine patients into disease criteria with the help of 
radiological grading of fatty liver and estimating cardiovascular risk score with the 
help of Framingham heart risk score in those patients with elevated gamma 
glutamyl transferase levels.  MATERIALS AND METHODS : This is a type of 
retrospective study conducted in Govt. Stanley medical college hospital measured 
in both out patients and in patients from the departments of general medicine and 
medical gasteroenterology in those who had radiological evidence of fatty liver 
ruling out other causes of any liver pre-existing liver abnormalities and estimating 
their levels of gamma glutamyl transferase levels using standardised testing 
protocols.  
RESULTS : In this study which was studied for a period of six months from May 
2017 – October 2017, it was observed that gamma glutamyl transferase levels was 
elevated in those patients with NAFLD and their cardiovascular risk and its 
outcome was calculated for the next 10 years calculated as mild , moderate and 
severe risk accordingly.The mean GGT levels were estimated to be closely similar 
to both males and females of about 56 -60 IU. CONCLUSION : Those patients 
who found to have fatty liver and confining within the criteria of NAFLD , when 
evaluated with their liver function tests it was found that gamma glutamyl 
transferase levels are elevated significantly .It has also proved that those with 
elevated GGT levels were independent of other risk factors like total cholesterol , 
smoking , systolic blood pressure whether treated or untreated Severity also 
depends upon the grading of fatty liver and its association with GGT levels. It also 
further showed that patients with persistently elevated gamma glutamyl transferase 
levels correlated with higher risk of cardiovascular risk score when compared 
accordingly using the traditional Framingham cardiovascular risk score when 
compared with differences among Sex , Age factors and their future risk when 
graded as per severity Index. Inspite of being included in liver function panel , 
Gamma Glutamyl Transferase is an enzyme primarily of hepatobiliary in origin .It 
serves as an index of future cardiovascular risk as it is also elevated in extra 
hepatic conditions including the cardiovascular and metabolic components.  
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